Docosanol

Revision as of 19:15, 27 September 2011 by WikiBot (talk | contribs) (Protected "Docosanol": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Docosanol
File:Docosan-1-ol.svg
Clinical data
Synonymsbenehic alcohol, benehyl alcohol, docosyl alcohol, n-docosanol
Pregnancy
category
  • US: B (No risk in non-human studies)
Routes of
administration
Topical
ATC code
Legal status
Legal status
Pharmacokinetic data
BioavailabilityNot absorbed
MetabolismN/A
Elimination half-lifeN/A
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC22H46O
Molar mass326.6 g/mol
Melting point71 °C (159.8 °F)
Boiling point180 °C (356 °F)

Docosanol is a drug used for topical treatment for recurrent herpes simplex labialis episodes (episodes of cold sores or fever blisters). A saturated 22-carbon aliphatic alcohol, docosanol exhibits antiviral activity against many lipid enveloped viruses including herpes simplex virus (HSV). Docosanol inhibits fusion between the plasma membrane and the herpes simplex virus (HSV) envelope, thereby preventing viral entry into cells and subsequent viral replication.

Abreva is the brand name of a cream containing 10% Docosanol. Abreva is the first over-the-counter anti-viral drug approved for sale in the United States and Canada.

External links

th:โดโคซานอล